ArticleJournal of nanobiotechnology2026
Correction: Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy.
Suqin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.